Videos & Webinars

Workshop: Advancement of PGx Testing – Development of Evidence-Based Guidelines and the Ongoing Effort to Drive Alignment with Regulatory Bodies

2 November 2022

Dr. Kelly E. Caudle discusses considerations behind CPIC guideline development and ongoing work to continually evolve the list of drug-gene interactions recognized by regulatory bodies. Learn about:

  • Translating genetic laboratory test results into actionable prescribing decisions
  • CPIC’s goal to address the barrier to clinical implementation of pharmacogenetic tests
  • Ongoing efforts to provide practice guidelines that align to actionable pharmacogenomic information

PRESENTED BY:
Dr. Kelly Caudle
Kelly E. Caudle, Pharm.D., Ph.D.
BCPS Principal Investigator and Director,
Clinical Pharmacogenetics Implementation Consortium

Learn more about our pharmacogenetics solutions.